BUSINESS BRIEFING / PHARMACEUTICALS
- Share via
Times Staff and Wire Reports
Warner Chilcott, an Irish maker of birth-control pills and acne medicine, said it would buy Procter & Gamble Co.’s prescription-drug unit for $3.1 billion.
Warner Chilcott will get products with $2.3 billion in annual sales, including Actonel for osteoporosis, and co-promotion rights to Enablex for bladder control, the companies said. Warner Chilcott shares rose the most in almost three years after the company said the deal would add to earnings right away.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
